Cynthia Sirard
Chief Tech/Sci/R&D Officer en LEAP THERAPEUTICS, INC. .
Fortuna: 13 300 $ al 31/03/2024
Perfil
Cynthia Sirard is currently the Chief Medical Officer at Leap Therapeutics, Inc. She started this position in 2020.
Previously, she worked as a Medical Director at PAREXEL International Corp from 2003 to 2005.
Dr. Sirard completed her undergraduate degree at the University of Massachusetts and obtained her doctorate from Chicago Medical School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LEAP THERAPEUTICS, INC.
0.02% | 29/01/2024 | 5 000 ( 0.02% ) | 13 300 $ | 31/03/2024 |
Cargos activos de Cynthia Sirard
| Empresas | Cargo | Inicio |
|---|---|---|
| LEAP THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2020 |
Antiguos cargos conocidos de Cynthia Sirard.
| Empresas | Cargo | Fin |
|---|---|---|
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | 01/01/2005 |
Formación de Cynthia Sirard.
| University of Massachusetts | Undergraduate Degree |
| Chicago Medical School | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
| Leap Therapeutics, Inc. |
- Bolsa de valores
- Insiders
- Cynthia Sirard
